{"id":1630,"date":"2023-03-29T13:48:08","date_gmt":"2023-03-29T13:48:08","guid":{"rendered":"http:\/\/wecare.sitedev.pt\/referencias-bibliograficas\/pourquoi-references-3\/"},"modified":"2023-03-29T13:50:05","modified_gmt":"2023-03-29T13:50:05","slug":"porque-3","status":"publish","type":"referencias-biblio","link":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/referencias-bibliograficas\/porque-3\/","title":{"rendered":"PORQU\u00ca – REFER\u00caNCIAS BIBLIOGR\u00c1FICAS"},"content":{"rendered":"
\n
\n
\n
\n
(EM GERAL)<\/h5>\n

1. Infarmed – Autoridade Nacional do Medicamento e Produtos de Sa\u00fade, I. P. Deliberac\u00e3o No. 11\/CD\/2019. January 31, 2019.<\/p>\n

2. US National Library of Medicine. ClinicalTrials.gov: Cannabis studies. Accessed September 1, 2021: https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=Cannabis&cntry=&state=&city=&dist=<\/p>\n<\/div>\n

\n
(DOR)<\/h5>\n

3. Di Marzo V, Piscitelli F. The endocannabinoid system and its modulation by phytocannabinoids. Neurotherapeutics. 2015 Oct;12(4): 692-8.<\/p>\n

4. Woodhams SG, Chapman V, Finn DP, Hohmann AG, Neugebauer V. The cannabinoid system and pain. Neuropharmacology. 2017 Sep; 124: 105-20.<\/p>\n

5. Health Canada. Information for Health Care Professionals: Cannabis and the cannabinoids. October 2018. ISBN: 978-0-660-27828-5.<\/p>\n

6. H\u00e4user W, Finn DP, Kalso E, et al. European Pain Federation (EFIC) position paper on appropriate use of cannabis-based medicines and medical cannabis for chronic pain management. Eur J Pain. 2018 Oct;22(9): 1547-64.<\/p>\n

7. Mesquita G, Pedro A, Fonseca B, Fonseca R. Recomenda\u00e7\u00f5es da Associa\u00e7\u00e3o Portuguesa para o Estudo da Dor (APED) para a utiliza\u00e7\u00e3o de canabinoides na dor cr\u00f3nica. APED. December 2020.<\/p>\n<\/div>\n

\n
(ESPASTICIDADE)<\/h5>\n

8. Centonze D. Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways. Eur Neurol. 2014;72 Suppl 1:6-8.<\/p>\n

9. Solari A, Giordano A, Sastre-Garriga J, et al. EAN guideline on palliative care of people with severe, progressive multiple sclerosis. Eur J Neurol. 2020 Aug;27(8): 1510-29.<\/p>\n

10. Sociedade Portuguesa de Neurologia [website]. Accessed December 20, 2021: https:\/\/www.spneurologia.com\/<\/p>\n<\/div>\n

\n
(PERDA DE APETITE)<\/h5>\n

11. Ezeoke CC, Morley JE. Pathophysiology of anorexia in the cancer cachexia syndrome. J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):287-302.<\/p>\n

12. Infarmed. Informa\u00e7\u00e3o aos profissionais de sa\u00fade sobre produtos \u00e0 base de can\u00e1bis medicinal. Tilray Flor Seca THC18. Aprovado em 27.01.2021.<\/p>\n

13. Radbruch L, Elsner F, Trottenberg P, Strasser F, Fearon K. Clinical Practice Guidelines on Cancer Cachexia in Advanced Cancer Patients. Aachen, Department of Palliative Medicine: European Palliative Care Research Collaborative; 2010.<\/p>\n

14. Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017 Feb;36(1): 11-48.<\/p>\n<\/div>\n<\/div>\n

\n
\n
(N\u00c1USEA & VOMITANDO)<\/h5>\n

15. Martin BR, Wiley JL. Mechanism of action of cannabinoids: how it may lead to treatment of cachexia, emesis, and pain. J Support Oncol. 2004 Jul-Aug;2(4): 305-14; discussion 314-6.<\/p>\n

16. Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015 Jun 23-30;313(24): 2456-73. Erratum in: JAMA. 2015 Aug 4;314(5):520. Erratum in: JAMA. 2015 Aug 25;314(8): 837. Erratum in: JAMA. 2015 Dec 1;314(21): 2308. Erratum in: JAMA. 2016 Apr 12;315(14): 1522. PMID: 26103030.<\/p>\n

17. Bar-Sela G, Vorobeichik M, Drawsheh S, Omer A, Goldberg V, Muller E. The medical necessity for medicinal cannabis: prospective, observational study evaluating the treatment in cancer patients on supportive or palliative care. Evid Based Complement Alternat Med. 2013 Jul;2013:510392.<\/p>\n

18. Haney M, Rabkin J, Gunderson E, Foltin RW. Dronabinol and marijuana in HIV(+) marijuana smokers: acute effects on caloric intake and mood. Psychopharmacology (Berl). 2005 Aug;181(1): 170-8.<\/p>\n

19. Haney M, Gunderson EW, Rabkin J, et al. Dronabinol and marijuana in HIV-positive marijuana smokers. Caloric intake, mood, and sleep. J Acquir Immune Defic Syndr. 2007 Aug;45(5): 545-54.<\/p>\n

20. Associa\u00e7\u00e3o Portuguesa de Cuidados Paliativos: Webcast Wecare – Utiliza\u00e7\u00e3o da Cannabis medicinal em contexto de Cuidados Paliativos [website]. July 14, 2021. Accessed December 20, 2021: https:\/\/apcp.com.pt\/157557\/webcast-wecare-utilizacao-da-cannabis-medicinal-em-contexto-de-cuidados-paliativos<\/p>\n

21. Sociedade Portuguesa de Oncologia. https:\/\/www.sponcologia.pt\/pt\/<\/p>\n

22. Berger MJ, Ettinger DS, Aston J, et al. NCCN Guidelines Insights: Antiemesis, Version 2.2017. J Natl Compr Canc Netw. 2017 Jul;15(7): 883-93.<\/p>\n<\/div>\n

\n
(EPILEPSIA)<\/h5>\n

23. Perucca E. Cannabinoids in the treatment of epilepsy: hard evidence at last? J Epilepsy Res. 2017 Dec;7(2):61-76.<\/p>\n

24. Rosenberg EC, Tsien RW, Whalley BJ, Devinsky O. Cannabinoids and epilepsy. Neurotherapeutics. 2015 Oct;12(4): 747-68.<\/p>\n

25. Epidyolex\u00ae Summary of Product Characteristics. GW Pharma. July 2021.<\/p>\n

26. McCoy B, Wang L, Zak M, et al. A prospective open-label trial of a CBD\/THC cannabis oil in dravet syndrome. Ann Clin Transl. Neurol. 2018 Aug; 5(9): 1077-88.<\/p>\n

27. Huntsman RJ, Tang-Wai R, Alcorn J, et al. Dosage related efficacy and tolerability of cannabidiol in children with treatment-resistant epileptic encephalopathy: preliminary results of the CARE-E Study. Front Neurol. 2019 Jul; 10: 716.<\/p>\n

28. Tzadok M, Uliel-Siboni S, Linder I, et al. CBD-enriched medical cannabis for intractable pediatric epilepsy: the current Israeli experience. Seizure. 2016 Feb;35:41-4.<\/p>\n

29. Caraballo R, Valenzuela GR. Cannabidiol-enriched medical cannabis as add-on therapy in children with treatment-resistant West syndrome: a study of eight patients. Seizure. 2021 Nov;92: 238-43.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

(EM GERAL) 1. Infarmed – Autoridade Nacional do Medicamento e Produtos de Sa\u00fade, I. P. Deliberac\u00e3o No. 11\/CD\/2019. January 31, 2019. 2. US National Library of Medicine. ClinicalTrials.gov: Cannabis studies. Accessed September 1, 2021: https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=Cannabis&cntry=&state=&city=&dist= (DOR) 3. Di Marzo V, Piscitelli F. The endocannabinoid system and its modulation by phytocannabinoids. Neurotherapeutics. 2015 Oct;12(4): 692-8. 4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"biblio-cats":[69],"class_list":["post-1630","referencias-biblio","type-referencias-biblio","status-publish","hentry","biblio-cats-profissionais-categorias"],"acf":[],"yoast_head":"\nPORQU\u00ca - REFER\u00caNCIAS BIBLIOGR\u00c1FICAS - WeCare<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/wecare-medicalcannabis.com\/pt-pt\/referencias-bibliograficas\/porque-3\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"PORQU\u00ca - REFER\u00caNCIAS BIBLIOGR\u00c1FICAS - WeCare\" \/>\n<meta property=\"og:description\" content=\"(EM GERAL) 1. Infarmed – Autoridade Nacional do Medicamento e Produtos de Sa\u00fade, I. P. Deliberac\u00e3o No. 11\/CD\/2019. January 31, 2019. 2. US National Library of Medicine. ClinicalTrials.gov: Cannabis studies. Accessed September 1, 2021: https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=Cannabis&cntry=&state=&city=&dist= (DOR) 3. Di Marzo V, Piscitelli F. The endocannabinoid system and its modulation by phytocannabinoids. Neurotherapeutics. 2015 Oct;12(4): 692-8. 4.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/wecare-medicalcannabis.com\/pt-pt\/referencias-bibliograficas\/porque-3\/\" \/>\n<meta property=\"og:site_name\" content=\"WeCare\" \/>\n<meta property=\"article:modified_time\" content=\"2023-03-29T13:50:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/wecare-medicalcannabis.com\/wp-content\/uploads\/2022\/12\/2-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1632\" \/>\n\t<meta property=\"og:image:height\" content=\"918\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/wecare-medicalcannabis.com\/pt-pt\/referencias-bibliograficas\/porque-3\/\",\"url\":\"https:\/\/wecare-medicalcannabis.com\/pt-pt\/referencias-bibliograficas\/porque-3\/\",\"name\":\"PORQU\u00ca - REFER\u00caNCIAS BIBLIOGR\u00c1FICAS - WeCare\",\"isPartOf\":{\"@id\":\"https:\/\/wecare-medicalcannabis.com\/pt-pt\/#website\"},\"datePublished\":\"2023-03-29T13:48:08+00:00\",\"dateModified\":\"2023-03-29T13:50:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/wecare-medicalcannabis.com\/pt-pt\/referencias-bibliograficas\/porque-3\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/wecare-medicalcannabis.com\/pt-pt\/referencias-bibliograficas\/porque-3\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/wecare-medicalcannabis.com\/pt-pt\/referencias-bibliograficas\/porque-3\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\/\/www.wecare-medicalcannabis.com\/pt-pt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PORQU\u00ca – REFER\u00caNCIAS BIBLIOGR\u00c1FICAS\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/wecare-medicalcannabis.com\/pt-pt\/#website\",\"url\":\"https:\/\/wecare-medicalcannabis.com\/pt-pt\/\",\"name\":\"WeCare\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/wecare-medicalcannabis.com\/pt-pt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/wecare-medicalcannabis.com\/pt-pt\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/wecare-medicalcannabis.com\/pt-pt\/#organization\",\"name\":\"WeCare\",\"url\":\"https:\/\/wecare-medicalcannabis.com\/pt-pt\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/wecare-medicalcannabis.com\/pt-pt\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/wecare.sitedev.pt\/wp-content\/uploads\/2022\/12\/logo-wecare.png\",\"contentUrl\":\"http:\/\/wecare.sitedev.pt\/wp-content\/uploads\/2022\/12\/logo-wecare.png\",\"width\":121,\"height\":72,\"caption\":\"WeCare\"},\"image\":{\"@id\":\"https:\/\/wecare-medicalcannabis.com\/pt-pt\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"PORQU\u00ca - REFER\u00caNCIAS BIBLIOGR\u00c1FICAS - WeCare","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/referencias-bibliograficas\/porque-3\/","og_locale":"pt_PT","og_type":"article","og_title":"PORQU\u00ca - REFER\u00caNCIAS BIBLIOGR\u00c1FICAS - WeCare","og_description":"(EM GERAL) 1. Infarmed – Autoridade Nacional do Medicamento e Produtos de Sa\u00fade, I. P. Deliberac\u00e3o No. 11\/CD\/2019. January 31, 2019. 2. US National Library of Medicine. ClinicalTrials.gov: Cannabis studies. Accessed September 1, 2021: https:\/\/clinicaltrials.gov\/ct2\/results?cond=&term=Cannabis&cntry=&state=&city=&dist= (DOR) 3. Di Marzo V, Piscitelli F. The endocannabinoid system and its modulation by phytocannabinoids. Neurotherapeutics. 2015 Oct;12(4): 692-8. 4.","og_url":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/referencias-bibliograficas\/porque-3\/","og_site_name":"WeCare","article_modified_time":"2023-03-29T13:50:05+00:00","og_image":[{"width":1632,"height":918,"url":"https:\/\/wecare-medicalcannabis.com\/wp-content\/uploads\/2022\/12\/2-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tempo estimado de leitura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/referencias-bibliograficas\/porque-3\/","url":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/referencias-bibliograficas\/porque-3\/","name":"PORQU\u00ca - REFER\u00caNCIAS BIBLIOGR\u00c1FICAS - WeCare","isPartOf":{"@id":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/#website"},"datePublished":"2023-03-29T13:48:08+00:00","dateModified":"2023-03-29T13:50:05+00:00","breadcrumb":{"@id":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/referencias-bibliograficas\/porque-3\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/wecare-medicalcannabis.com\/pt-pt\/referencias-bibliograficas\/porque-3\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/referencias-bibliograficas\/porque-3\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.wecare-medicalcannabis.com\/pt-pt\/"},{"@type":"ListItem","position":2,"name":"PORQU\u00ca – REFER\u00caNCIAS BIBLIOGR\u00c1FICAS"}]},{"@type":"WebSite","@id":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/#website","url":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/","name":"WeCare","description":"","publisher":{"@id":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"pt-PT"},{"@type":"Organization","@id":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/#organization","name":"WeCare","url":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/","logo":{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/#\/schema\/logo\/image\/","url":"http:\/\/wecare.sitedev.pt\/wp-content\/uploads\/2022\/12\/logo-wecare.png","contentUrl":"http:\/\/wecare.sitedev.pt\/wp-content\/uploads\/2022\/12\/logo-wecare.png","width":121,"height":72,"caption":"WeCare"},"image":{"@id":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/wp-json\/wp\/v2\/referencias-biblio\/1630","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/wp-json\/wp\/v2\/referencias-biblio"}],"about":[{"href":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/wp-json\/wp\/v2\/types\/referencias-biblio"}],"author":[{"embeddable":true,"href":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=1630"}],"version-history":[{"count":2,"href":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/wp-json\/wp\/v2\/referencias-biblio\/1630\/revisions"}],"predecessor-version":[{"id":1637,"href":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/wp-json\/wp\/v2\/referencias-biblio\/1630\/revisions\/1637"}],"wp:attachment":[{"href":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=1630"}],"wp:term":[{"taxonomy":"biblio-cats","embeddable":true,"href":"https:\/\/wecare-medicalcannabis.com\/pt-pt\/wp-json\/wp\/v2\/biblio-cats?post=1630"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}